Telomerase plays a key role in the maintenance of chromosomal stability in tumors, but the mechanism regulating telomerase activity is still unclear. Recent studies have suggested that c-myc may be vital for regulation of hTERT mRNA expression and telomerase activity. In this study, we investigated the changes of telomerase activity and telomerase 
Introduction
Telomerase, a RNA-dependent DNA polymerase, synthesizes telomere repeats that protect the integrity of chromosomes. [1] [2] [3] [4] Most somatic cells express low or undetectable levels of telomerase, and cessation of cell division occurs when the telomeres become critically shortened. 5, 6 A few somatic cells such as mitogen-stimulated lymphocytes and proliferative-phase endometrium possess telomerase activity, as do most human malignancies. 7, 8 Thus, telomerase is thought to be associated with cell proliferation. This enzyme consists of a template RNA component (hTERC) containing the complementary sequence of TTAGGG and two proteins, which are telomerase-associated protein (TEP-1) and telomerase reverse transcriptase (hTERT). [9] [10] [11] [12] [13] hTERC is ubiqitously expressed regardless of the level of telomerase activity. In contrast, hTERT is considered to be important in the control of telomerase activity, because its expression closely correlated with the telomerase positivity of cells. However, the regulatory mech- anism for telomerase has not been elucidated fully despite extensive investigations.
We previously reported that herbimycin A downregulates the expression of cyclin D1 and c-myc through the inhibition of bcr-abl fusion kinase in K562 cells. 14 Recently, it was demonstrated that c-myc upregulates the expression of hTERT mRNA through its promoter activity. [15] [16] [17] [18] [19] [20] [21] In the present study, we investigated the changes of telomerase activity in relation to modulation of c-myc, cyclin D1, and hTERT during herbimycin A treatment of K562 cells. We found that herbimycin A downregulated both hTERT expression and telomerase activity following the downregulation of c-myc and cyclin D1. Ectopic expression of hTERT could counteract the downregulation of telomerase activity by herbimycin A, while ectopic expression of either c-myc or cyclin D1 failed to do so.
Materials and methods

Cells and culture
K562 cells (derived from a patient with chronic myelogenous leukemia in blastic crisis) were obtained from the Riken cell bank (Tsukuba, Japan). Cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (Hyclone, Logan, UT, USA) containing 100 U/ml penicillin and 100 g/ml streptomycin (Gibco BRL, Gaithersburg, MD, USA) in a 5% CO 2 incubator with 100% humidity. Exponentially growing cells (2 × 10 5 /ml) were suspended in 10 ml of culture medium containing 0.8 M herbimycin A (Kyowa, Tokyo), as described previously.
14 Most of the treated cells remained viable despite the inhibition of growth, as confirmed by trypan blue staining and propidium iodide (PI)-Hoechst33342 double staining (Sigma, St Louis, MO, USA).
Transfection of hTERT-, c-myc-and cyclin D1
The plasmid (pCI-neo-hTERT) containing the full-length cDNA of hTERT was a kind gift from R Weinberg (White Head Institute, MIT, MA, USA). A c-myc expression vector was constructed as follows. First, the full-length c-myc cDNA was amplified from a template c-myc cDNA (pSPT-c-myc; obtained from Japanese Cancer Research Resources Bank, Tokyo, Japan) using the following primers: 5Ј-TAGAATTCCGCGACGATGCCCCTC-3Ј (sense) and 5Ј-GATCTAGATTTTCCTTACGCACAA-3Ј (antisense). The amplified fragment was cloned into the pcDNA3 vector (Invitrogen, Carlsbad, CA, USA) at the EcoRI and XbaI sites. The full-length cDNA of cyclin D1, obtained from SI Reed (The Scripps Research Institute, CA, USA), was inserted into the pcDNA3 vector at the NatI site. Then, 20 g aliquots of the expression vector were transfected by electropolation using a Gene Pulser apparatus (BioRad, Hercules, CA, USA) at 280 V and 960 F at room temperature. Transfected cells were selected in 800 g/ml G418 (Gibco) selection medium, and finally a single colony was isolated from methylcellulose semisolid medium. 10 
Cell cycle analysis
Cells (approximately 5 × 10 5 ) were fixed in 70% ethanol, and stored at 4°C before staining. For staining, the fixed cells were removed from the ethanol by centrifugation, resuspended in PBS with trypsin and RNase, and stained with PI. After 30 min of incubation at 37°C, the cells were immediately analyzed with a FACS Calibur (Becton Dickinson, San Jose, CA, USA).
Telomerase assay
The telomerase assay was performed using a TRAP EZE Telomerase Detection Kit (Oncor, Gaithersburg, MD, USA), as described elsewhere. 22 For a more sensitive and semiquantitative assay, each extract of K562 cells was diluted 1:20, so that an aliquot of 0.5 l corresponded to 250 cells. After 10 min of incubation at 30°C, the polymerase chain reaction (PCR) amplification was performed with 30 cycles of 94°C for 30 s and 60°C for 30 s. The PCR products were analyzed by electrophoresis on 12% polyacrylamide nondenaturating gels and stained with SYBR Green I (Molecular Probes, Eugene, OR, USA). Then, the gels were photographed using a CCD camera (Fuji Film, Tokyo, Japan) and an ultraviolet transilluminator (Ultra-Lum, CA, USA). Telomerase ladders were analyzed using NIH image analysis software. The telomerase activity was assessed by determining the ratio of the entire telomerase ladder to that of the internal control. Relative telomerase activity was determined by comparison with that of control cells prior to treatment (0 h). The direct effect of herbimycin A on telomerase activity was analyzed by adding this drug to the telomerase reaction mixture and incubating the mixture for 10 min at 30°C, after which it was processed for the telomerase assay.
RNA isolation and reverse-transcriptase polymerase chain reaction (RT-PCR)
Total RNA was isolated using an Isogen RNA extraction kit (Nippongene, Toyama, Japan). The first-strand cDNA was synthesized using M-MLV reverse transcriptase (Gibco), as described previously.
14 Briefly, 6 g of total RNA was transcribed using a random hexamer primer (Pharmacia Biotech, Uppsala, Sweden) in a reaction mixture with a total volume of 30 l. PCR was done using 1.5 l of first-strand cDNA and a thermal cycler (Gene Amp PCR system 2400-R; Perkin Elmer, Norwalk, CT, USA). The reaction sequence was 94°C for 30 s, 60°C for 30 s, and 72°C for 60 s (25 cycles for hTERT, hTERC, TEP-1, c-myc, and cyclin D1 and 21 cycles for ␤-actin). The amplified products were separated on 2% agarose gel. Gels were stained with ethidium bromide and photographed using an ultraviolet transilluminator and a CCD camera (Toyobo, Osaka, Japan). The primer sets employed were as follows: for hTERT, 22, 23 5Ј-TGAACTTGCGGAAGA-CAGTGG-3Ј (sense) and 5Ј-ATGCGTGAAACCTGTACGCCT-3Ј (antisense); for hTERC, 22 ,23 5Ј-TTTGTCTAACCCTAACTGA-GAAG-3Ј (sense) and 5Ј-TTGCTCTAGAATGAACGGTGGA-3Ј Leukemia (antisense); for TEP-1, 22 ,23 5Ј-TCAAGCCAAACCTGAATCTGAG-3Ј (sense) and 5Ј-CCCCGAGTGAATCTTTCTACGC-3Ј (antisense); for c-myc, 14 5Ј-AAGACTCCAGCGCCTTCTCTC-3Ј (sense) and 5Ј-GTTTTCCAACTCCGGGATCTG-3Ј (antisense); for cyclin D1, 24, 25 5Ј-ACCTGGATGCTGGAGGTCTG-3Ј (sense) and 5Ј-GAACTTCA-CATCTGTGGCACA-3Ј (antisense); for ␤-actin, 22 5Ј-GTGGGGC-GCCCCAGGCACCA-3Ј (sense) and 5Ј-CTCCTTAATGTCACGC-ACGATTTC-3Ј (antisense).
Western blotting
Cells were washed with ice-cold TBS buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl), and lysed in EBC buffer (50 mM TrisHCl, pH 8.0, 120 mM NaCl, 0.5% Nonidet P-40, 100 mM sodium fluoride, 200 mM sodium orthovanadate) containing protease inhibitors, as described previously. 26 An equal amount (60 g) of the samples was separated on 7.5% SDSpolyacrylamide gel and transferred on to nitrocellulose filters (BioRad). After blocking in TBS buffer with 4% bovine serum albumin (Fraction V; Sigma), the membranes were incubated for 16 h with 1 g/ml anti-c-Myc monoclonal antibody (Pharmingen, San Diego, CA, USA), and the bands were visualized by an enhanced chemiluminescence system (Amersham, Buckinghamshire, UK).
Results
Modulation of telomerase activity and telomeraserelated genes in K562 cells by herbimycin A
The proliferation of K562 cells was suppressed by herbimycin A, when compared with untreated cells (data not shown). Herbimycin A induced accumulation of cells in G1 phase, with a peak at 12 h (Figure 1a ). This cell cycle modulation was also noted in our previous study.
14 Changes of telomerase activity with herbimycin A treatment are shown in Figure 1b . Peak telomerase activity was observed at 12 h, but it was steeply downregulated to less than 20% of the control level (0 h) by 18 h. Subsequently, telomerase activity slowly recovered in accordance with the increment of S phase cells and it returned to 30% of the control level by 48 h.
To investigate the regulation of telomerase activity in the presence of herbimycin A treatment, changes of c-myc and cyclin D1 expression were studied by RT-PCR (Figure 1b) . Both genes were transiently downregulated from 3 h to 6 h, as reported previously. 14 We also studied the expression of hTERT, hTERC and TEP-1. Neither hTERC nor TEP-1 mRNA were altered along with herbimycin A treatment, while hTERT mRNA was downregulated from 6 to 18 h, preceding the decline of telomerase activity. Interestingly, the downregulation of hTERT mRNA was also transient and it returned to the control level by 24 h (Figure 1b) .
Modulation of telomerase activity and telomeraserelated genes by herbimycin A in c-myc-transfected K562 cells
The downregulation of telomerase activity during herbimycin A treatment was concommitant with the downregulation of c-myc, cyclin D1, and hTERT, so we next studied whether these genes were responsible for telomerase downregulation. For this purpose, we constructed transformants which consti-
Figure 1
Modulation of telomerase activity by herbimycin A in K562 cells. (a) Analysis of the cell cycle and relative telomerase activity. The cell cycle was analyzed by flow cytometry and the percentage of cells in each phase is shown. Relative telomerase activity is shown as hatched bars. Control telomerase activity (0 h) was defined as relative telomerase level 1, and the telomerase activity at each designated times was compared to that of the control level. (b) Changes of telomerase activity and various genes. Cells were harvested at the designated times, and protein and mRNA were extracted as described in the text. A gel from the telomerase assay is shown. hTERT, hTERC, TEP-1, cyclin D1, c-myc and ␤-actin were detected by RT-PCR. c-Myc protein was detected by immunoblotting.
tutively expressed different introduced genes. When c-myctransfected K562 cells were treated with herbimycin A, the cell cycle changes were similar to those of untransfected K562 cells (Figure 2a ). G1 growth arrest peaked at 12 h, but the maximum accumulation in G1 phase was less than K562 cells and G1 accumulation declined more rapidly. This suggested that c-myc overexpression conferred partial resistance to the growth arrest induced by herbimycin A. Telomerase activity in c-myc-transfected K562 cells was also suppressed by herbimycin A treatment, but the magnitude of the decrease was smaller than in control K562 cells (Figure 2b) . The reduction was about 40% of that in control cells (0 h) at 12 and 18 h, and it recovered almost to the control level at 24 h. The changes of mRNA expression were also studied ( Figure 2b) . As c-myc was expressed ectopically, the early downregulation of c-myc expression observed in control cells did not occur. The c-myc protein level showed the same pattern as the mRNA level. Nevertheless, cyclin D1 was downregulated at 3 h to 6 h in c-myc-transfected K562 cells. Neither hTERC nor TEP-1 was altered, as in untransfected K562 cells, while the changes of hTERT differed from those observed in control cells. The early downregulation of hTERT from 3 h to 6 h in untransfected K562 cells was delayed to 12 h in the c-myctransfected cells and hTERT was normalized by 24 h.
Modulation of telomerase activity and telomeraserelated genes by herbimycin A in cyclin D1-transfected K562 cells
Next, we studied the effect of cyclin D1 transfection on telomerase activity. The changes of the cell cycle were basically similar to those in untransfected K562 cells, although the maximum accumulation in G1 phase was observed at 18 h (Figure 3a) . Recovery of the cell cycle to baseline was observed at 48 h, as in untransfected K562 cells. Telomerase activity was decreased at 12-24 h, and was increased slightly at 48 h (Figure 3b ). This pattern was similar to untransfected K562 cells, although the recovery at 48 h was twice as great. Transient downregulation of hTERT mRNA was observed at 6-18 h, prior to the decline of telomerase activity, and upregulation of hTERT mRNA was observed after 24 h, whereas there were no significant changes of hTERC and TEP-1 mRNA (Figure 3b) . Downregulation of c-myc mRNA expression was seen at 3-6 h. Early downregulation of cyclin D1 was not observed, but it was slightly decreased during the latter half of herbimycin A treatment (Figure 3b ).
Modulation of telomerase activity and telomeraserelated genes by herbimycin A in hTERT-transfected K562 cells
Finally, we studied the effect of hTERT. Growth of hTERTtransfected K562 cells was also suppressed by herbimycin A (data not shown), and G1 phase cells were increased from 51.9% to 61.4% at 12 h (Figure 4a) . However, the changes of telomerase activity were totally different from those in untransfected K562 cells, c-myc-transfected cells, and cyclin D1-transfected cells (Figure 4b ). Early downregulation of telomerase activity was not observed. Neither hTERC nor TEP-1 were altered, and hTERT also showed stable expression with 
Discussion
A large number of human cancers have high levels of telomerase activity, whereas most normal somatic cells have little or no activity. Because telomerase plays a key role in the maintenance of chromosomal stability in tumors, inhibition of this enzyme may induce tumor cell apoptosis. In fact, inhibition of telomerase using an antisense telomerase expression vector not only decreases telomerase activity but also increases the susceptibility of cells to cisplatin-induced apoptotic death. 27 Also, a dominant-negative hTERT mutant dramatically reduces telomerase activity, and the resulting telomere-shortened tumor cells become susceptible to apoptosis. 28 Therefore, study of the mechanism regulating telomerase activity is important to develop a telomerase-specific inhibitor. Our previous study demonstrated that interferon-␣ downregulated hTERT expression in Daudi cells due to a decrement of c-Myc protein, and then repressed telomerase activity along with accumulation of the cells in G1 phase. 23 To further assess the relationship between telomerase activity and the proliferation of leukemic cells, we focused on the response of telomerase to herbimycin A-induced cell cycle modulation. Herbimycin A, a potent inhibitor of bcr-abl fusion kinase, not only inhibited the proliferation of K562 cells but also caused a decrease of telomerase activity. During herbimycin A treatment, we found that three genes (cyclin D1, c-myc and hTERT) were markedly downregulated. Transfection of any of these genes failed to overcome herbimycin A-induced accumulation in G1 phase, although the extent of G1 accumulation varied. In cyclin D1-transfected K562 cells, the pattern of both cell cycle arrest and telomerase downregulation was close to that in untransfected K562 cells, suggesting that the role of cyclin D1 in telomerase regulation was insignificant.
In contrast, c-myc overexpression partly counteracted the effect of herbimycin A on both the cell cycle and telomerase activity, with telomerase inhibition being reduced in both extent and duration. Recent studies have suggested that expression of the telomerase catalytic subunit, hTERT, is mainly responsible for the activity of this enzyme. 29, 30 hTERT gene expression is controlled at the transcriptional level, and c-Myc has been suggested as an important transcription factor involved in the positive regulation of hTERT expression. 21 c-myc is one of the most frequently activated proto-oncogenes, so hTERT expression in tumor cells may partly depend on the expression of c-myc. In this study, we demonstrated that simple c-myc overexpression did not overcome herbimycin A-induced inhibition of telomerase activity. Even in cmyc-transfected cells, hTERT expression varied in correspondence with the changes of telomerase activity. This suggests that other signals elicted from the bcr-abl fusion kinase may be more important for activation of the hTERT promoter. Recently, Kang et al 31 reported that telomerase is upregulated through the phosphorylation of hTERT protein by Akt kinase. Considering that one of the signals from the bcr-abl fusion kinase is transduced into the PI-3 kinase and Akt kinase pathway, further studies are needed to assess the relationship between this fusion gene and telomerase activation.
In this study, we demonstrated that cyclin D1 is not important for telomerase activity, while c-myc only partly reversed the herbimycin A-induced downregulation of telomerase. In contrast, direct expression of hTERT was able to completely reverse downregulation of telomerase activity. These findings suggest that either transcriptional or post-translational modification of hTERT may be able to control telomerase activity in leukemic cells.
